| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/18/1993 | WO1993003160A1 Synthetic storage proteins with defined structure containing programmable levels of essential amino acids for improvement of the nutritional value of plants |
| 02/18/1993 | WO1993003159A1 Highly stable recombinant yeasts for the production of recombinant proteins |
| 02/18/1993 | WO1993003158A1 System for protein expression and secretion especially in corynebacteria |
| 02/18/1993 | WO1993003153A1 Nucleotide sequences coding for ribosome inactivating proteins |
| 02/18/1993 | WO1993003151A1 Treatment of cell populations |
| 02/18/1993 | WO1993003148A2 Tau/neurofilament protein kinases pk40 and pk36 |
| 02/18/1993 | WO1993003146A1 Disease associated b-cell epitopes of tpo and use thereof |
| 02/18/1993 | WO1993003145A1 Infectious bursal disease virus recombinant poxvirus vaccine |
| 02/18/1993 | WO1993003057A1 Polypeptides capable of in vivo induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of p.falciparum, related products and their use in producing vaccine compositions |
| 02/18/1993 | WO1993003050A1 Novel cyclophilins, associating proteins and uses |
| 02/18/1993 | WO1993002703A1 Prodrugs activated by targeted catalytic proteins |
| 02/18/1993 | WO1993002702A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
| 02/18/1993 | WO1993002698A1 Monoclonal antibodies to leukocyte adhesion molecule-1 |
| 02/18/1993 | CA2114950A1 Treatment of cell populations |
| 02/18/1993 | CA2114942A1 Novel cyclophilins, associating proteins and uses |
| 02/18/1993 | CA2114934A1 Prodrugs activated by targeted catalytic proteins |
| 02/18/1993 | CA2114409A1 Nucleotide sequences coding for ribosome inactivating proteins |
| 02/18/1993 | CA2114223A1 Polypeptides capable of in vivo induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of p. falciparum, related products and their use in producing vaccine compositions |
| 02/18/1993 | CA2113551A1 Highly stable recombinant yeasts for the production of recombinant proteins |
| 02/18/1993 | CA2113280A1 Disease associated b-cell epitopes of tpo and use thereof |
| 02/18/1993 | CA2111116A1 Improved expression of influenza a m2 protein in baculovirus and uses of m2 protein |
| 02/18/1993 | CA2110505A1 Infectious bursal disease virus recombinant poxvirus vaccine |
| 02/18/1993 | CA2083273A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
| 02/17/1993 | EP0514488A4 Retinoid receptor compositions and methods |
| 02/17/1993 | EP0245479B1 Shortened phosphoglycerate kinase promoter |
| 02/17/1993 | CN1069124A Antibodies and method for their use |
| 02/16/1993 | US5187261 Peptide sequence of first seven amino acids of lambda bacteriophage protein fused to human serum albumin |
| 02/16/1993 | US5187153 Methods of treatment using Alzheimer's amyloid polypeptide derivatives |
| 02/16/1993 | US5187091 Bacillus thuringiensis cryiiic gene encoding toxic to coleopteran insects |
| 02/16/1993 | US5187090 For tumor diagnosis |
| 02/16/1993 | US5187089 Variants wherein there are nonpolar amino acid substitutions at the substrate binding site |
| 02/16/1993 | US5187087 Recominbant herpesvirus of turkeys and live vector vaccines derived thereof |
| 02/16/1993 | US5187086 Molecules with antibody combining sites that catalyze hydrolysis reactions through use of a charged hapten |
| 02/16/1993 | US5187082 Cultivating Amycolatopsis albus or mutant under submerged aerobic fermentation |
| 02/16/1993 | US5187077 Leukaemia inhibitory factor |
| 02/16/1993 | US5187075 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses |
| 02/16/1993 | US5187063 Combining a muscle sample with antibodies which specifically bind to glycoprotein component of dystrophin/glycoprotein complex, detecing extent of binding and comparing with extent of binding in nondystrophic muscle tissue samples |
| 02/16/1993 | US5186933 Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system |
| 02/14/1993 | WO1993004165A1 DNA SEQUENCE ENCODING BOVINE α-LACTALBUMIN AND METHODS OF USE |
| 02/13/1993 | CA2075771A1 Enzymatic synthesis of renin inhibitors |
| 02/13/1993 | CA2075748A1 Enzymatic deprotection of peptides |
| 02/10/1993 | EP0526953A1 Multichain polypeptides or proteins and processes for their production |
| 02/10/1993 | EP0526952A2 Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same |
| 02/10/1993 | EP0526905A2 Multimers of the soluble forms of TNF receptors, their preparation and pharmaceutical compositions containing them |
| 02/10/1993 | EP0526888A2 Monoclonal antibody reactive with human pancreas cancer tissue |
| 02/10/1993 | EP0526577A1 Methods for removing ligands from a particle surface. |
| 02/10/1993 | EP0526452A1 Hybrid immunoglobulins |
| 02/10/1993 | EP0402415B1 Synthetic scm-active cancer recognition peptides |
| 02/10/1993 | EP0396563B1 Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
| 02/10/1993 | CA2075611A1 Non-a, non-b hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody, and detection systems |
| 02/09/1993 | US5185441 Polypeptides that bind to CD2, the receptor on the surface of T-cells |
| 02/09/1993 | US5185432 Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas |
| 02/09/1993 | US5185321 Adding lysozyme to Lactobeicillus, incubating, hydrolyzing peptidoglycans, centriguging, adding to whey or fermented milk |
| 02/09/1993 | US5185258 Subtilisin mutants |
| 02/09/1993 | US5185254 Gene family of tumor-associated antigens |
| 02/09/1993 | US5185148 Applying bioinsecticide |
| 02/07/1993 | CA2075343A1 Monoclonal antibody and uses of the same |
| 02/04/1993 | WO1993002358A1 Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies oxa and oxb |
| 02/04/1993 | WO1993002206A1 Purification of recombinant ciliary neurotrophic factor and c-terminal truncated ciliary neurotrophic factor and methods for treating peripheral nerve damage |
| 02/04/1993 | WO1993002192A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | WO1993002191A1 Humanized antibody against cd18 |
| 02/04/1993 | WO1993002190A1 Production of antibodies |
| 02/04/1993 | WO1993002108A1 Recombinant antibodies for human therapy |
| 02/04/1993 | WO1993002106A1 Neural calcium-activated neutral proteinase inhibitors |
| 02/04/1993 | WO1993002097A1 Protein v: a novel igg binding factor |
| 02/04/1993 | WO1992013950A3 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF β CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 02/04/1993 | DE4224050A1 Loesliche kit-liganden Soluble kit ligand |
| 02/04/1993 | DE4222416A1 Monoclonal antibody specific for prostatic acid phosphatase - shows very little cross-reactivity with phosphatase(s) from platelets, erythrocytes or leukocytes, for prostatic cancer diagnosis |
| 02/04/1993 | DE4122599A1 Oberflaechen-expressionsvektor zum screenen von antikoerpern A roughness expression vector for antibody screening |
| 02/04/1993 | CA2113993A1 Protein v: a novel igg binding factor |
| 02/04/1993 | CA2113815A1 Purification of recombinant ciliary neurotrophic factor and c-terminal truncated ciliary neurotrophic factor and methods for treating peripheral nerve damage |
| 02/04/1993 | CA2113801A1 Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies oxa and oxb |
| 02/04/1993 | CA2113206A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | CA2113202A1 Neural calcium-activated neutral proteinase inhibitors |
| 02/04/1993 | CA2111858A1 Production of antibodies |
| 02/03/1993 | EP0525910A1 Non-A, non-B peptide |
| 02/03/1993 | EP0525828A2 Recombinant polypeptides and their uses, including assay for aids virus |
| 02/03/1993 | EP0525570A2 Anti-idiotypic antibodies that mimic TNF |
| 02/03/1993 | EP0525508A2 Anti-palnogenic protein of ustilago maydis and use thereof |
| 02/03/1993 | EP0525054A1 Modified heparin binding growth factors |
| 02/03/1993 | EP0386076B1 Phosphoryled derivatives of cardiodilatine/anf peptides |
| 02/03/1993 | EP0233915B1 Molecular farming |
| 02/03/1993 | CN1068501A A-c-b proinsulin, method of manufacturing and using same, and intermediates in insulin production |
| 02/03/1993 | CA2075165A1 Non-a, non-b peptide |
| 02/02/1993 | US5183884 Novel proteins (erbB-3 gene) of the erB proto-oncogene family; immunoassay; antitumor and -carcinogenic agents |
| 02/02/1993 | US5183755 Anti-human papillomavirus monoclonal antibody, hybridoma producing the same and process for preparing the same |
| 02/02/1993 | US5183739 Hybridoma which produces antibody binds to an epitope on glycohemoglobin comprising epsilon-d-fructosyllysine is useful for diagnosis of diseases |
| 02/02/1993 | US5183734 Antibodies, diagnostic systems and methods for assaying SV40 HBxAg |
| 02/01/1993 | CA2074662A1 Anti-idiotypic antibodies that mimic tnf |
| 01/27/1993 | EP0524906A1 DNA coding for prolylendopeptidase |
| 01/27/1993 | EP0524899A1 Recombinant DNA molecules coding for the VB2 T cell receptor, method of preparation, antibodies and medicaments containing them |
| 01/27/1993 | EP0524832A2 Activator gene for macrolide biosynthesis |
| 01/27/1993 | EP0524737A2 Protein s. polypeptides and anti-peptide antibodies that inhibit protein s binding TO C4b binding protein, diagnostic systems and therapeutic methods |
| 01/27/1993 | EP0524681A1 Process for the purification of serum albumin |
| 01/27/1993 | EP0524672A1 CCV vaccine |
| 01/27/1993 | EP0524421A1 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use |
| 01/27/1993 | EP0524260A1 GPIb$g(a) FRAGMENTS AND RECOMBINANT DNA EXPRESSION VECTORS |
| 01/27/1993 | EP0348442B1 Altered antibody |
| 01/27/1993 | CN1068335A Hepatitis c diagnostics and vaccines |
| 01/27/1993 | CN1068266A Vaccine and treatment method for human immunodeficiency virus |